SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-024348
Filing Date
2020-05-11
Accepted
2020-05-11 17:08:15
Documents
46
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gwph-10q_20200331.htm   iXBRL 10-Q 1239372
2 EX-31.1 gwph-ex311_7.htm EX-31.1 16434
3 EX-31.2 gwph-ex312_6.htm EX-31.2 16469
4 EX-32.1 gwph-ex321_9.htm EX-32.1 6032
5 EX-32.2 gwph-ex322_8.htm EX-32.2 6124
  Complete submission text file 0001564590-20-024348.txt   3754445

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA gwph-20200331.xsd EX-101.SCH 26056
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gwph-20200331_cal.xml EX-101.CAL 45434
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gwph-20200331_def.xml EX-101.DEF 51091
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gwph-20200331_lab.xml EX-101.LAB 219129
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gwph-20200331_pre.xml EX-101.PRE 150529
18 EXTRACTED XBRL INSTANCE DOCUMENT gwph-10q_20200331_htm.xml XML 510200
Mailing Address SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE CB24 9BZ X0 00000
Business Address SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE CB24 9BZ X0 00000 44 1223 266800
GW PHARMACEUTICALS PLC (Filer) CIK: 0001351288 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35892 | Film No.: 20865941
SIC: 2834 Pharmaceutical Preparations